← Back to home
· Corrected

Pfizer Raises Its 2026 Forecast as Eliquis and Cancer Drugs Offset Falling Covid Sales

Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources

Brief

Pfizer raised its 2026 forecast on Tuesday after a third quarter in which Eliquis and several cancer drugs nearly made up for steep drops…

Keep reading with NewsPlain Premium

Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.

4 sources behind this story.

Updates

Correction, : The $135 million, or 33%, increase covers combined global Nurtec ODT and Vydura sales. The reported sales declines for Paxlovid, Comirnaty and the Prevnar family exclude currency effects.
About this story

This story includes a public correction.

How NewsPlain works
← Back to home